EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stock Under $10 that he thinks could potentially double or triple in the next 6 to 12-months. See what he's trading today with a 14-day FREE pass.

Reprint Email

TheStreet Wire

Natus Medical Stock Hits New 52-Week Low (BABY)

By TheStreet Wire 08/05/11 - 11:39 AM EDT

Find out if (BABY) is in Cramer's Portfolio.

NEW YORK (TheStreet) -- Natus Medical (Nasdaq:BABY) hit a new 52-week low Friday as it is currently trading at $10.54, below its previous 52-week low of $10.56 with 71,004 shares traded as of 11:14 a.m. ET. Average volume has been 314,400 shares over the past 30 days.

Natus Medical has a market cap of $317.9 million and is part of the health care sector and health services industry. Shares are down 25% year to date as of the close of trading on Thursday.

Natus Medical Incorporated develops, manufactures, and markets neurodiagnostic and newborn care products worldwide. The company has a P/E ratio of 26.7, above the average health services industry P/E ratio of 21.5 and above the S&P 500 P/E ratio of 17.7.

Practice your BABY trading strategies and win cash in our stock game.

TheStreet Ratings rates Natus Medical as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and unimpressive growth in net income. You can view the full Natus Medical Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.

For more information on Natus Medical Inc. click any of the following:

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:

$2.5+ million portfolio
Large-cap and dividend focus
Intraday trade alerts from Cramer
Weekly roundups

Dividend Stock Advisor

TRY IT FREE

New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:

Diversified model portfolio of dividend stocks
Alerts when market news affect the portfolio
Bi-weekly updates with exact steps to take - BUY, HOLD, SELL

Stocks Under $10

TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:

Model portfolio
Stocks trading below $10
Intraday trade alerts
Weekly roundups

Real Money

TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:

Jim Cramer + 20 Wall Street pros
Intraday commentary & news
Real-time trading forum
Actionable trade ideas

Real Money Pro

TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:

Real Money + Doug Kass + 15 more Wall Street Pros
Intraday commentary & news
Ultra-actionable trading ideas

Options Profits

TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.